Sign In
Buy OPRX
$4.95
-0.330 (-6.25%)
At Close: Jun 03, 2026
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million
07:31am, Monday, 25'th Jan 2021
ROCHESTER, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported prelim
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
07:31am, Thursday, 21'st Jan 2021
ROCHESTER, Mich., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been in
Nuance: Look Beyond The Numbers
11:12am, Tuesday, 19'th Jan 2021
Nuance: Look Beyond The Numbers
OptimizeRx: You Made Me A Believer
12:36pm, Wednesday, 06'th Jan 2021
OptimizeRx did not disappoint on Q3'20 financials, beating on both revenue and EPS. Revenue was up 110% YoY. Strong forward efficiency score of 40% suggests that OptimizeRx is in fine shape based on g
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
07:31am, Wednesday, 06'th Jan 2021
ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been in
OptimizeRx's TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
07:31am, Friday, 11'th Dec 2020
TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and Providers TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and Providers
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
07:31am, Wednesday, 09'th Dec 2020
ROCHESTER, Mich., Dec. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invite
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
07:31am, Monday, 07'th Dec 2020
Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving Support for Providers and Patients Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
07:31am, Tuesday, 01'st Dec 2020
For the First Time, Real-World Data is Used to Deliver Real-Time Care Support Information at the Point-Of-Care For the First Time, Real-World Data is Used to Deliver Real-Time Care Support Information
Do Hedge Funds Love OptimizeRx Corporation (OPRX)?
09:33am, Sunday, 29'th Nov 2020
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™
07:31am, Wednesday, 18'th Nov 2020
Attributes 217% Revenue Growth to Rapidly Expanding Digital Health Platform Attributes 217% Revenue Growth to Rapidly Expanding Digital Health Platform
OptimizeRx and Questex's Fierce Life Sciences Tackle Industry's Top Challenges in Design Thinking Event, Innovate4Outcomes
10:30am, Tuesday, 17'th Nov 2020
Event Brings Providers and Life Sciences Leaders Together to Collaborate on Solutions for Better Patient Outcomes Event Brings Providers and Life Sciences Leaders Together to Collaborate on Solutions
Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation
OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2020 Results - Earnings Call Transcript
10:25pm, Monday, 09'th Nov 2020
OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2020 Results - Earnings Call Transcript
OptimizeRx: Q3 Earnings Insights
04:45pm, Monday, 09'th Nov 2020
Shares of OptimizeRx (NASDAQ:OPRX) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 240.00% over the past year to $0.07, which beat t
